Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
14%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
1
11%
Ph phase_3
1
11%
Ph early_phase_1
1
11%
Ph not_applicable
3
33%
Ph phase_4
3
33%

Phase Distribution

2

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
3(33.3%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(7)
Terminated(2)

Detailed Status

Completed7
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 11 (11.1%)
Phase 31 (11.1%)
Phase 43 (33.3%)
N/A3 (33.3%)

Trials by Status

terminated111%
withdrawn111%
completed778%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_1

Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat

NCT04299633
withdrawnnot_applicable

Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate

NCT00364000
completedearly_phase_1

Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion.

NCT01991574
terminatedphase_4

Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4

NCT01277497
completednot_applicable

A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD

NCT00785629
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT04299633Phase 1

Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat

Completed
NCT00364000Not Applicable

Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate

Withdrawn
NCT01991574Early Phase 1

Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion.

Completed
NCT01277497Phase 4

Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4

Terminated
NCT00785629Not Applicable

A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD

Completed
NCT01135615Phase 4

Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)

Completed
NCT00211978Phase 3

EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)

Completed
NCT00211939Phase 4

CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients

Completed
NCT00018135Not Applicable

Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9